It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mutations in RNA binding proteins (RBPs) and in genes regulating autophagy are frequent causes of familial amyotrophic lateral sclerosis (fALS). The P56S mutation in vesicle-associated membrane protein-associated protein B (VAPB) leads to fALS (ALS8) and spinal muscular atrophy (SMA). While VAPB is primarily involved in the unfolded protein response (UPR), vesicular trafficking and in initial steps of the autophagy pathway, the effect of mutant P56S-VAPB on autophagy regulation in connection with RBP homeostasis has not been explored yet. Examining the muscle biopsy of our index ALS8 patient of European origin revealed globular accumulations of VAPB aggregates co-localised with autophagy markers LC3 and p62 in partially atrophic and atrophic muscle fibres. In line with this skin fibroblasts obtained from the same patient showed accumulation of P56S-VAPB aggregates together with LC3 and p62. Detailed investigations of autophagic flux in cell culture models revealed that P56S-VAPB alters both initial and late steps of the autophagy pathway. Accordingly, electron microscopy complemented with live cell imaging highlighted the impaired fusion of accumulated autophagosomes with lysosomes in cells expressing P56S-VAPB. Consistent with these observations, neuropathological studies of brain and spinal cord of P56S-VAPB transgenic mice revealed signs of neurodegeneration associated with altered protein quality control and defective autophagy. Autophagy and RBP homeostasis are interdependent, as demonstrated by the cytoplasmic mis-localisation of several RBPs including pTDP-43, FUS, Matrin 3 which often sequestered with P56S-VAPB aggregates both in cell culture and in the muscle biopsy of the ALS8 patient. Further confirming the notion that aggregation of the RBPs proceeds through the stress granule (SG) pathway, we found persistent G3BP- and TIAR1-positive SGs in P56S-VAPB expressing cells as well as in the ALS8 patient muscle biopsy. We conclude that P56S-VAPB-ALS8 involves a cohesive pathomechanism of aberrant RBP homeostasis together with dysfunctional autophagy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Katona Istvan 2
; Doukas Panagiotis 2 ; Nikolin Stefan 2 ; Ernst, Sabrina 5 ; Aronica Eleonora 6 ; Glaß Hannes 7 ; Hermann, Andreas 8 ; Steinbusch Harry 9 ; Feller, Alfred C 10 ; Bergmann, Markus 11 ; Jaarsma Dick 12 ; Weis Joachim 2 ; Goswami, Anand 2
1 RWTH Aachen University Medical School, Institute of Neuropathology, Aachen, Germany (GRID:grid.1957.a) (ISNI:0000 0001 0728 696X); EURON - European Graduate School of Neuroscience, Maastricht, The Netherlands (GRID:grid.1957.a)
2 RWTH Aachen University Medical School, Institute of Neuropathology, Aachen, Germany (GRID:grid.1957.a) (ISNI:0000 0001 0728 696X)
3 RWTH Aachen University Medical School, Institute of Biomedical Engineering, Department of Cell Biology, Aachen, Germany (GRID:grid.1957.a) (ISNI:0000 0001 0728 696X)
4 RWTH Aachen University Medical School, Institute of Neuropathology, Aachen, Germany (GRID:grid.1957.a) (ISNI:0000 0001 0728 696X); Bern University Hospital, University of Bern, Department of Neurosurgery, Inselspital, Bern, Switzerland (GRID:grid.411656.1) (ISNI:0000 0004 0479 0855)
5 RWTH Aachen University, Institute of Biochemistry and Molecular Biology, Aachen, Germany (GRID:grid.1957.a) (ISNI:0000 0001 0728 696X); RWTH Aachen University, Confocal Microscopy Facility, Interdisciplinary Center for Clinical Research IZKF, Aachen, Germany (GRID:grid.1957.a) (ISNI:0000 0001 0728 696X)
6 University of Amsterdam, Department of (Neuro) Pathology, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands (GRID:grid.484519.5)
7 University Medical Center Rostock, University of Rostock, Translational Neurodegeneration Section “Albrecht-Kossel”, Department of Neurology and Center for Transdisciplinary Neurosciences Rostock (CTNR), Rostock, Germany (GRID:grid.10493.3f) (ISNI:0000000121858338)
8 University Medical Center Rostock, University of Rostock, Translational Neurodegeneration Section “Albrecht-Kossel”, Department of Neurology and Center for Transdisciplinary Neurosciences Rostock (CTNR), Rostock, Germany (GRID:grid.10493.3f) (ISNI:0000000121858338); German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany (GRID:grid.10493.3f)
9 EURON - European Graduate School of Neuroscience, Maastricht, The Netherlands (GRID:grid.10493.3f); Maastricht University, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht, The Netherlands (GRID:grid.5012.6) (ISNI:0000 0001 0481 6099)
10 University Hospital of Schleswig-Holstein, Hämatopathologie Lübeck, Reference Centre for Lymph Node Pathology and Haematopathology, Lübeck, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097)
11 Institute für Neuropathologie, Bremen-Mitte, Bremen, Germany (GRID:grid.412468.d)
12 Erasmus MC, Department of Neuroscience, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)




